KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,692,793 | +2518.0% | 212,596 | +1521.8% | 0.00% | – |
| Q1 2023 | $141,053 | -95.6% | 13,109 | -93.9% | 0.00% | -100.0% |
| Q4 2022 | $3,199,099 | +1697.2% | 213,558 | +1441.4% | 0.00% | – |
| Q3 2022 | $178,000 | +50.8% | 13,855 | +13.3% | 0.00% | – |
| Q2 2022 | $118,000 | +4.4% | 12,233 | +7.3% | 0.00% | – |
| Q1 2022 | $113,000 | -15.0% | 11,396 | +1.4% | 0.00% | – |
| Q4 2021 | $133,000 | -8.3% | 11,240 | -11.7% | 0.00% | – |
| Q3 2021 | $145,000 | -5.2% | 12,736 | +15.9% | 0.00% | – |
| Q2 2021 | $153,000 | -88.0% | 10,985 | -78.1% | 0.00% | – |
| Q2 2020 | $1,276,000 | +2.4% | 50,074 | +12.9% | 0.00% | – |
| Q4 2018 | $1,246,000 | – | 44,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |